From Nature for LifeBiotest Pharmaceuticals Corporation was created as a U.S. subsidiary of Biotest AG in December 2007. Innovative technologies and a sharp focus on safety are incorporated into every facet of the business. Biotest AG has a rich history in the development and manufacture of pharmaceutical and biotherapeutic products utilized in immunology and hematology. From plasma collection to product manufacturing and distribution from nature for life Biotest Pharmaceuticals Corporation is committed to maintaining these same high standards of excellence.2000sBiotest introduces its fully automated blood typing system, and begins clinical testing of new monoclonal antibodies. The plasma protein business and the Biologics Business Unit of Nabi Biopharmaceuticals is acquired by Biotest AG in 2007.TodayBiotest continues its principal mission of introducing new disease fighting therapies with a series of significant developmental products in its pipeline.